These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


168 related items for PubMed ID: 6584649

  • 1. [Remission induction and maintenance with multi-drug regimen (modified LSA2L2) for acute lymphoblastic leukemia in children].
    Shitara T, Kuribayashi T, Oshima Y, Hiraishi Y.
    Rinsho Ketsueki; 1983 Nov; 24(11):1479-83. PubMed ID: 6584649
    [No Abstract] [Full Text] [Related]

  • 2. [Consolidating chemotherapy in the treatment program of acute lymphoblastic leukemia in children].
    Maiakova SA, Makhonova LA.
    Vestn Akad Med Nauk SSSR; 1986 Nov; (5):15-7. PubMed ID: 3487897
    [No Abstract] [Full Text] [Related]

  • 3. [Treatment of acute lymphoblastic leukemia in children: modified LSA2-L2 therapy].
    Ishii E, Hara T, Ueda K, Kishida K, Nakamura E, Miyazaki S, Yoshida N.
    Rinsho Ketsueki; 1985 Apr; 26(4):487-93. PubMed ID: 3862888
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Results of the treatment of lymphoblastic leukemia by the BFM program in children--a 5-year observation].
    Rokicka-Milewska R, Derulska D, Makowska K, Skwarska E, Lewicki Z.
    Acta Haematol Pol; 1987 Apr; 18(1-2):1-8. PubMed ID: 3481150
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Influence of intensive induction and consolidation therapy in acute lymphoblastic leukaemia in children.
    Sanchetee SC, Pai SK, Pai VR, Kurkure PA, Shetty PA.
    Indian J Cancer; 1985 Sep; 22(3):217-20. PubMed ID: 3870462
    [No Abstract] [Full Text] [Related]

  • 9. [Use of high doses of methotrexate in the program treatment of children with lymphoblastic leukemia].
    Maiakova SA, Balakirev SA, Gavrilova IE, Drozdova TS, Makhonova LA.
    Gematol Transfuziol; 1985 Jul; 30(7):12-5. PubMed ID: 3863771
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Induction toxicity of a modified Memorial Sloan-Kettering-New York II Protocol in children with relapsed acute lymphoblastic leukemia: a single institution study.
    Morland BJ, Shaw PJ.
    Med Pediatr Oncol; 1996 Sep; 27(3):139-44. PubMed ID: 8699989
    [Abstract] [Full Text] [Related]

  • 12. [Treatment and prognosis after late relapse in childhood acute lymphoblastic leukemia].
    Ikuta K, Fujioka K, Takahashi H, Sumita H, Sekiguchi H, Hanzawa N, Kai S, Kajigaya Y, Funabiki T, Okuyama T.
    Rinsho Ketsueki; 1993 Jun; 34(6):712-7. PubMed ID: 8366572
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Results of the CCLSG high risk ALL 874 protocol in childhood acute lymphoblastic leukemia. Children's Cancer and Leukemia Study Group].
    Kawai S, Fujimoto T, Zha Z, Asami K, Oka T, Kaneko Y, Takaue Y, Ninomiya T, Nishikawa K, Tsuchiya T.
    Rinsho Ketsueki; 1993 Feb; 34(2):128-36. PubMed ID: 8492409
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.